Pazopanib improves progression-free survival without impairing quality of life

In patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life, research shows. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1H4zb0H